SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor in the world and the third leading cause of cancer-associated deaths. A Sleeping Beauty-mediated transposon mutagenesis screen previously identified mutations that cooperate with MYC to accelerate liver tumorigenesis. This revealed...
Main Authors: | Shruthy Suresh, Deniz Durakoglugil, Xiaorong Zhou, Bokai Zhu, Sarah A Comerford, Chao Xing, Xian-Jin Xie, Brian York, Kathryn A O'Donnell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-03-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5362238?pdf=render |
Similar Items
-
Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
by: Shruthy Suresh, et al.
Published: (2018-04-01) -
SRC-2 Is an Essential Coactivator for Orchestrating Metabolism and Circadian Rhythm
by: Erin Stashi, et al.
Published: (2014-02-01) -
SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart.
by: Erin L Reineke, et al.
Published: (2012-01-01) -
Implications of the Estrogen Receptor Coactivators SRC1 and SRC2 in the Biological Basis of Gender Incongruence
by: Karla del Valle Ramírez, Pre-doc, et al.
Published: (2021-06-01) -
SRC-3, a Steroid Receptor Coactivator: Implication in Cancer
by: Licen Li, et al.
Published: (2021-04-01)